ResMed (NYSE:RMD) Price Target Lowered to $269.00 at KeyCorp
ResMed (NYSE:RMD – Get Free Report) had its price target cut by equities research analysts at KeyCorp from $280.00 to $269.00 in a report issued on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the medical equipment provider’s stock. KeyCorp’s price target points to a potential upside of 25.46% from the company’s current […]
ResMed (NYSE:RMD – Get Free Report) had its price target cut by equities research analysts at KeyCorp from $280.00 to $269.00 in a report issued on Monday,Benzinga reports. The brokerage presently has an “overweight” rating on the medical equipment provider’s stock. KeyCorp’s price target points to a potential upside of 25.46% from the company’s current […]
